Results 41 to 50 of about 58,938 (145)

Practical Strategy for Treating Chronic Kidney Disease (CKD)-Associated with Hypertension

International Journal of Nephrology and Renovascular Disease, 2020
Daisuke Nagata, Erika Hishida, Takahiro Masuda Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Tochigi, JapanCorrespondence: Daisuke Nagata Tel +81 285 58 7346Fax +81 285 44 4869Email nagatad@jichi.ac.jpAbstract: When ...
Nagata D, Hishida E, Masuda T
doaj  

SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES

Рациональная фармакотерапия в кардиологии, 2015
Topical issues of cardiovascular disease pharmacotherapy influencing function of the renin-angiotensin-aldosterone system are discussed. Efficacy and safety of two major cardiovascular drug classes, angiotensin converting enzyme inhibitors and sartans ...
K. A. Gyamdzhyan, M. L. Maksimov
doaj   +1 more source

Angiotensin-converting-enzyme gene insertion-deletion polymorphism and renin angiotensin aldosterone system activity in different phenotypes of polycystic ovary syndrome

Heliyon
Polycystic ovary syndrome (PCOS) is a common condition. Its pathophysiology involves an interaction between genetic and environmental factors, resulting in different reproductive and metabolic subtypes.
Khansa Chaabouni, Amana Saadallah-Kallel, Samia Ben Brahim, Kais Chaabane, Madiha Frikha, Mouna Mnif, Leila Keskes, Fatma Abdelhedi, Fatma Ayadi   +8 more
doaj   +1 more source

Prior Use of Renin-Angiotensin System Inhibitors and Risk of Renal Replacement Therapy in Critically Ill Elderly Patients With Sepsis: A Population-Based Cohort Study

Critical Care Explorations
OBJECTIVES:. We sought to estimate the association between chronic use of renin-angiotensin system inhibitors and acute kidney injury requiring renal replacement therapy in critically ill adult patients with sepsis. DESIGN:. Population-based cohort study
Victoria Otero Castro, MD, Damon C. Scales, MD, PhD, Federico Angriman, MD, MPH, PhD   +2 more
doaj   +1 more source

Renin inhibitors are a new direction in the treatment of arterial hypertension

Терапевтический архив, 2010
The paper covers current problems in the treatment of arterial hypertension. Renin is an important and promising therapeutic target. The direct renin inhibitor aliskiren (Rasilez) is a promising current effective antihypertensive agent that has cardio ...
Yuriy Aleksandrovich Vasyuk, Irina Akhmedkhanovna Sadulaeva, Elena Nikolaevna Yushchuk, Ol'ga Sergeevna Trofimenko, Mikhail Vasil'evich Chirkov, Viktoriya Sergeevna Fedoseeva, Kirill Georgievich Kulikov, Yu A Vasyuk, I A Sadulayeva, E N Yushchuk, O S Trofimenko, M V Chirkov, V S Fedoseyeva, K G Kulikov   +13 more
doaj  

Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension. [PDF]

Cochrane Database Syst Rev, 2020
Wang GM, Li LJ, Tang WL, Wright JM.
europepmc   +1 more source

Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules. [PDF]

Bioorg Med Chem, 2020
Ramya K, Suresh R, Kumar HY, Kumar BRP, Murthy NBS.   +4 more
europepmc   +1 more source

RENIN INHIBITORS

Journal of clinical hypertension (Greenwich, Conn.), 2012
KEY POINTS AND PRACTICAL RECOMMENDATIONS: •  Aliskiren, the sole oral renin inhibitor approved by the US Food and Drug Administration, is indicated for the treatment of hypertension, either as monotherapy or in combination, with reductions in blood pressure similar to other agents. •  Early evidence suggests that aliskiren confers additional benefit in
MCKAY DANIEL J, ARBOUR MELISSA, ASPIOTIS RENEE, CHEN AUSTIN, DOLMAN SARAH JENNIFER, FOURNIER PIERRE-ANDRE, GALLANT MICHEL, HAN YONGXIN, HUGHES GREG, JANEY JACOB, JUTEAU HELENE, LACOMBE PATRICK, LALIBERTE SEBASTIEN, LAUZON SOPHIE, MACDONALD DWIGHT, MACKAY BRUCE, MELLON CHRISTOPHE, MOLINARO CARMELA, MORLEY KRISTA L, O'SHEA PAUL   +19 more
openaire   +3 more sources

Income‐Level and Immigrant Status Are Associated With Discontinuation of Evidence‐Based Secondary Prevention Therapies After Myocardial Infarction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Mechanisms for worse prognosis after myocardial infarction in low socioeconomic status are unclear. We therefore investigated the association between socioeconomic status and discontinuation of evidence‐based secondary prevention drug ...
Joel Ohm, Kevin Ma, Sara Freyland, Ali Yari, Tomas Jernberg, Per Svensson   +5 more
doaj   +1 more source

Renin Inhibitors [PDF]

New England Journal of Medicine, 1978
openaire   +4 more sources